The identification and validation of Auger electron-emitting radiopharmaceuticals targeting telomerase for cancer therapy

The identification and validation of Auger electron-emitting radiopharmaceuticals targeting telomerase for cancer therapy

<p>Telomerase is expressed in the majority (>85%) of tumours but not in differentiated normal tissue. This enzyme catalyses the elongation of telomeres – a process critical for continued cell proliferation. Telomerase is a potential novel target for molecularly-targeted radiotherapy (mR...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awdur:	Jackson, M
Awduron Eraill:	Vallis, K
Fformat:	Traethawd Ymchwil
Iaith:	English
Cyhoeddwyd:	2013
Pynciau:	Tumours Medical Sciences Oncology Translational biology Radiation

Eitemau Tebyg

Selective targeting of homologous recombination deficiency
gan: Zimmer, J
Cyhoeddwyd: (2014)

Targeting EGFR signalling pathway in triple negative breast cancer
gan: Albukhari, A
Cyhoeddwyd: (2014)

Targeting EGFR signalling pathway in triple negative breast cancer
gan: Albukhari, A
Cyhoeddwyd: (2014)

Development of models and methods to assess the efficacy of anti-cancer drugs targeted to the mitochondria
gan: Potter, M
Cyhoeddwyd: (2014)

Radiopharmaceutical Validation for Clinical Use
gan: Charles A. Kunos, et al.
Cyhoeddwyd: (2021-03-01)

The role of ATF4 in hypoxia-induced cell death in cancer
gan: Pike, L, et al.
Cyhoeddwyd: (2011)

Novel signalling pathways regulating epithelial-mesenchymal transition in bone metastatic prostate cancer
gan: Rao, SR
Cyhoeddwyd: (2014)

Towards quantitative intra-nuclear dose mapping of auger emitting radionuclides used for targeted radiotherapy
gan: Royle, G
Cyhoeddwyd: (2016)

The three methyls: the function and therapeutic potential of histone H3K36 trimethylation
gan: Pfister, SX
Cyhoeddwyd: (2014)

Development of molecular targeted imaging methods for detection of lung metastasis and angiogenesis
gan: Melemenidis, S
Cyhoeddwyd: (2014)

Tumour-stroma interaction in pancreatic cancer
gan: Lunardi, S
Cyhoeddwyd: (2013)

Characterising the role of circulating immune cells in brain metastasis
gan: Balathasan, L
Cyhoeddwyd: (2012)

Real-time studies of DNA repair kinetics following low-LET short-pulse electron radiation
gan: Mendes de Oliveira Martins, CD
Cyhoeddwyd: (2014)

Development of clinical biomarkers of DNA double strand breaks for cancer care
gan: Shah, K
Cyhoeddwyd: (2012)

Investigating a role of ASPP2 in the cellular response to infection
gan: Lim, Y, et al.
Cyhoeddwyd: (2014)

MRI and histological analysis of brain metastasis and the effect of systemic inflammation
gan: Hamilton, AMA
Cyhoeddwyd: (2013)

Targeting cell adhesion as a method of sensitising metastatic tumour cells to TRAIL-induced apoptosis
gan: Phipps, L
Cyhoeddwyd: (2011)

CEA-targeted monoclonal antibody therapy in colorectal cancer
gan: Conaghan, P, et al.
Cyhoeddwyd: (2009)

Selective permeabilisation of the blood-brain barrier at sites of metastasis.
gan: Connell, JJ
Cyhoeddwyd: (2014)

The role of host microenvironment in the pathogenesis of multiple myeloma
gan: Lwin, STS
Cyhoeddwyd: (2014)

Heterogeneity of tumour response to hypoxia: carbonic anhydrase IX induction defines a subpopulation of hypoxic cells with stem cell properties and drug resistance
gan: Ledaki, I
Cyhoeddwyd: (2013)

Combining regulatory angiogenic gene therapy and virotherapy for the treatment of breast cancer
gan: Bazan Peregrino, M
Cyhoeddwyd: (2007)

The role of DLL4-NOTCH signalling in endothelial cell metabolism
gan: Harjes, U
Cyhoeddwyd: (2014)

Recent advances in radiation research for human health and environment
gan: Amit Kumar, et al.
Cyhoeddwyd: (2017-01-01)

Development of bioreductive inhibitors of checkpoint kinase 1 to target hypoxic tumours
gan: Körner, C
Cyhoeddwyd: (2015)

Functional analysis of cancer/testis antigens in human cancer
gan: Pagotto, A
Cyhoeddwyd: (2013)

Telomerase-targeting radiopharmaceuticals for the selective treatment of cancer
gan: Bavelaar, B
Cyhoeddwyd: (2018)

Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF
gan: Knowles, H, et al.
Cyhoeddwyd: (2008)

Mitochondrial modulators of hypoxia-related pathways in tumours
gan: Snell, CE
Cyhoeddwyd: (2013)

Modulating the immune system by amino acid depletion - IDO and beyond
gan: Vallius, L
Cyhoeddwyd: (2011)

Activities, procedures and doses in pediatric patients due to radiopharmaceuticals
gan: Silvia Maria Velasques de Oliveira, et al.
Cyhoeddwyd: (2008-12-01)

Targeting PDK and PARP to improve radiation response in preclinical models of non-small cell lung cancer
gan: Verbiest, T
Cyhoeddwyd: (2013)

The role of LATS1 in DNA damage signalling
gan: Latusek, R
Cyhoeddwyd: (2012)

Lactylation in cancer: Mechanisms in tumour biology and therapeutic potentials
gan: Yipeng He, et al.
Cyhoeddwyd: (2024-11-01)

Cytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/neu in breast cancer and is an independent predictor of prognosis
gan: Winters, Z, et al.
Cyhoeddwyd: (2003)

The role of nitric oxide as a hypoxic cell radiosensitizer
gan: Folkes, L
Cyhoeddwyd: (2013)

Improving intraperitoneal adenovirus virotherapy for ovarian cancer
gan: Thoma, CMM
Cyhoeddwyd: (2011)

E2F7: a member of the E2F family with a novel mechanism of transcriptional repression
gan: Kesoglidou, PX
Cyhoeddwyd: (2012)

Predicting survival of patients with spinal metastatic disease using PathFx 3.0 – A validation study of 668 patients in Sweden
gan: Christian Carrwik, et al.
Cyhoeddwyd: (2022-01-01)

Understanding the anti-tumour immune response to radionuclide therapy using PSMA targeting radiopharmaceuticals in a prostate cancer model
gan: Anderson, R
Cyhoeddwyd: (2021)